Johnson & Johnson Beats Procter & Gamble for 20-Year Dividend Growth

When choosing between two Dividend Kings, Johnson & Johnson (NYSE: JNJ) and Procter & Gamble (NYSE: PG), for a 20-year holding period, Johnson & Johnson emerges as the stronger pick. Both companies trade at nearly identical valuations, with forward earnings multiples of around 21 times. However, the decision hinges on three critical factors: dividend coverage, business durability, and structural risk.

Procter & Gamble boasts a longer dividend track record, having raised its payout for 70 consecutive years compared to Johnson & Johnson’s 64. P&G also offers a higher yield at 2.98%, versus J&J’s 2.12%. Yet, Johnson & Johnson has better dividend coverage, with its payout consuming about 46% of adjusted earnings, leaving more room for future increases. P&G’s dividend takes up roughly 62% of its earnings, limiting its flexibility.

In terms of business durability, Procter & Gamble holds an edge due to its stable demand for essential products like Tide and Pampers. However, Johnson & Johnson faces structural risks, including legal challenges and declining sales of its Stelara drug. Despite these issues, J&J’s diverse portfolio, with 28 products each generating over $1 billion annually, provides resilience.

Overall, Johnson & Johnson wins two out of three key factors, making it the preferred choice for long-term investors. Its lower payout ratio and stronger growth prospects give it an advantage over Procter & Gamble, which may struggle with flat earnings and rising dividend ratios. While P&G suits retirees seeking higher current yields, J&J offers a more sustainable dividend profile for a 20-year horizon.